News
Under terms of the deal, Alchemab will lead early Phase I trials for ATLX-1282 in amyotrophic lateral sclerosis, while Lilly ...
Following President Trump's executive order, the Indian pharmaceutical industry anticipates a surge in unannounced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback